Living on the edge with too many mouths to feed: Why dopamine neurons die

Abstract

Although genes, protein aggregates, environmental toxins, and other factors associated with Parkinson's disease (PD) are widely distributed in the nervous system and affect many classes of neurons, a consistent feature of PD is the exceptional and selective vulnerability of dopamine (DA) neurons of the SNc. What is it about these neurons, among all other neurons in the brain, that makes them so susceptible in PD? We hypothesize that a major contributory factor is the unique cellular architecture of SNc DA neuron axons. Their large, complex axonal arbour puts them under such a tight energy budget that it makes them particularly susceptible to factors that contribute to cell death, including unique molecular characteristics associated with SNc DA neurons and nonspecific, nervous‐system–wide factors. © 2012 Movement Disorder Society

Shown for reading. Its publisher allows quoting it, not republishing it.

References 57

1. 1.

   Martin I, Dawson VL, Dawson TM. The impact of genetic research on our understanding of Parkinson’s disease. Prog Brain Res. 2010;183:21-41.

   Not in our library10.1016/s0079-6123(10)83002-x

2. 2.

   Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. Lancet Neurol. 2008;7:97-109.

   Not in our library10.1016/s1474-4422(07)70327-7

3. 3.

   Sulzer D. Multiple hit hypotheses for dopamine neuron loss in Parkinson’s disease. Trends Neurosci. 2007;30:244-250.

   Not in our library10.1016/j.tins.2007.03.009

4. 4.

   Gasser T. Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects. Prog Brain Res. 2010;183:3-20.

   Not in our library10.1016/s0079-6123(10)83001-8

5. 5.

   Obeso JA, Rodriguez-Oroz MC, Goetz CG. Missing pieces in the Parkinson’s disease puzzle. Nat Med. 2010;16:653-661.

   Not in our library10.1038/nm.2165

6. 6.

   Surmeier DJ, Guzman JN, Sanchez-Padilla J. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson’s disease. Cell Calcium. 2010;47:175-182.

   Not in our library10.1016/j.ceca.2009.12.003

7. 7.

   Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, Surmeier DJ. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. 2010;468:696-700.

   Not in our library10.1038/nature09536

8. 8.

   Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA. What causes the death of dopaminergic neurons in Parkinson’s disease? Prog Brain Res. 2010;183:59-77.

   Not in our library10.1016/s0079-6123(10)83004-3

9. 9.

   Chan CS, Guzman JN, Ilijic E. ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease. Nature. 2007;447:1081-1086.

   Not in our library10.1038/nature05865

10. 10.

    Van Laar VS, Dukes AA, Cascio M, Hastings TG. Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease. Neurobiol Dis. 2008;29:477-489.

    Not in our library10.1016/j.nbd.2007.11.007

11. 11.

    Van Laar VS, Mishizen AJ, Cascio M, Hastings TG. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol Dis. 2009;34:487-500.

    Not in our library10.1016/j.nbd.2009.03.004

12. 12.

    Berman SB Hastings TG. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease. J Neurochem. 1999;73:1127-1137.

    Not in our library10.1046/j.1471-4159.1999.0731127.x

13. 13.

    Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson’s disease. Nature. 1988;334:345-348.

    Not in our library10.1038/334345a0

14. 14.

    Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F. The role of the locus coeruleus in the development of Parkinson’s disease. Neurosci Biobehav Rev. 2000;24:655-668.

    Not in our library10.1016/s0149-7634(00)00028-2

15. 15.

    Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318:121-134.

    Not in our library10.1007/s00441-004-0956-9

16. 16.

    Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol. 2002;249(Suppl 3):III/1-5.

    Not in our library10.1007/s00415-002-1301-4

17. 17.

    Meredith GE, Halliday GM, Totterdell S. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson’s disease: new insights into Lewy body formation. Parkinsonism Relat Disord. 2004;10:191-202.

    Not in our library10.1016/j.parkreldis.2004.01.001

18. 18.

    Langston JW. MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci. 1985;36:201-206.

    Not in our library10.1016/0024-3205(85)90059-1

19. 19.

    Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron. 2008;57:760-773.

    Not in our library10.1016/j.neuron.2008.01.022

20. 20.

    Sherer TB, Kim JH, Betarbet R, Greenamyre JT. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol. 2003;179:9-16.

    Not in our library10.1006/exnr.2002.8072

21. 21.

    Drolet RE, Cannon JR, Montero L, Greenamyre JT. Chronic rotenone exposure reproduces Parkinson’s disease gastrointestinal neuropathology. Neurobiol Dis. 2009;36:96-102.

    Not in our library10.1016/j.nbd.2009.06.017

22. 22.

    Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nat Neurosci. 2000;3:1301-1306.

    Not in our library10.1038/81834

23. 23.

    Moss J, Bolam JP. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci. 2008;28:11221-11230.

    Not in our library10.1523/jneurosci.2780-08.2008

24. 24.

    Moss J, Bolam JP, Iversen LL, Iversen SD, Dunnett SB, Björklund A. The relationship between dopaminergic axons and glutamatergic synapses in the striatum: structural considerations. Dopamine Handbook New York Oxford University Press. 2010;49-59.

    Not in our library

25. 25.

    Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009;29:444-453.

    Not in our library10.1523/jneurosci.4029-08.2009

26. 26.

    Andén NE, Fuxe K, Hamberger B, Hökfelt T. A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta Physiol Scand. 1966;67:306-312.

    Not in our library10.1111/j.1748-1716.1966.tb03317.x

27. 27.

    Björklund A, Lindvall O, Björklund A, Hökfelt T. Dopamine-containing sytems in the CNS. Handbook of Chemical Neuroanatomy Amsterdam Elsevier. 1984;55-122.

    Not in our library

28. 28.

    Wickens J, Arbuthnott GW, Dunnett SB, Bentivoglio M, Björklund A, Hökfelt T. Strutural and functional interactions in the striatum at the receptor level. Handbook of Chemical Neuroanatomy Amsterdam Elsevier. 2005;199-236.

    Not in our library

29. 29.
    Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat · 2008

    No notice
30. 30.

    Oorschot DE. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol. 1996;366:580-599.

    Not in our library10.1002/(sici)1096-9861(19960318)366:4<580::aid-cne3>3.0.co;2-0

31. 31.

    Bevan MD, Booth PAC, Eaton SA, Bolam JP. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci. 1998;18:9438-9452.

    Not in our library10.1523/jneurosci.18-22-09438.1998

32. 32.

    Kawaguchi Y, Wilson CJ, Emson PC. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci. 1990;10:3421-3438.

    Not in our library10.1523/jneurosci.10-10-03421.1990

33. 33.

    Kita H, Kitai ST. The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain Res. 1994;636:308-319.

    Not in our library10.1016/0006-8993(94)91030-8

34. 34.

    Tepper JM, Bolam JP. Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol. 2004;14:685-692.

    Not in our library10.1016/j.conb.2004.10.003

35. 35.

    Wu Y, Richard S, Parent A. The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res. 2000;38:49-62.

    Not in our library10.1016/s0168-0102(00)00140-1

36. 36.

    Furuta T, Tomioka R, Taki K, Nakamura K, Tamamaki N, Kaneko T. In vivo transduction of central neurons using recombinant Sindbis virus: Golgi-like labeling of dendrites and axons with membrane-targeted fluorescent proteins. J Histochem Cytochem. 2001;9:1497-1508.

    Not in our library10.1177/002215540104901203

37. 37.

    Fujiyama F, Sohn J, Nakano T, Furuta T, Nakamura KC, Matsuda W, Kaneko T. Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci. 2011;33:668-677.

    Not in our library10.1111/j.1460-9568.2010.07564.x

38. 38.

    Ohno S, Kuramoto E, Furuta T. A morphological analysis of thalamocortical axon fibers of rat posterior thalamic nuclei: a single neuron tracing study with viral vectors. Cerebral Cortex. 2011.

    Not in our library10.1093/cercor/bhr356

39. 39.

    Prensa L, Parent A. The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J Neurosci. 2001;21:7247-7260.

    Not in our library10.1523/jneurosci.21-18-07247.2001

40. 40.

    Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21:1133-1145.

    Not in our library10.1097/00004647-200110000-00001

Cited by papers we hold 20

• Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction · 2023
  No notice
• Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential · 2023
  No notice
• The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease · 2022
  Not checked
• Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease · 2021
  Not checked
• In vitro Models of Neurodegenerative Diseases · 2020
  No notice
• PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease · 2020
  No notice
• Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause? · 2020
  No notice
• Modeling Parkinson’s Disease With the Alpha-Synuclein Protein · 2020
  No notice
• Mechanisms and roles of mitochondrial localisation and dynamics in neuronal function · 2020
  No notice
• GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases · 2020
  No notice
• Axonal Transport and Mitochondrial Function in Neurons · 2019
  No notice
• On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease · 2018
  No notice
• Forgetting in Reinforcement Learning Links Sustained Dopamine Signals to Motivation. · 2016
  Not checked
• Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives · 2016
  No notice
• Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies · 2015
  No notice
• Impaired intracellular trafficking defines early Parkinson's disease · 2015
  No notice
• Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update · 2014
  No notice
• “Is dopamine involved in Alzheimer's disease?†· 2014
  No notice
• Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons · 2014
  No notice
• The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.